C.M. Bidwell & Associates’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8
Closed -$306 468
2025
Q1
$306 Hold
8
﹤0.01% 427
2024
Q4
$351 Hold
8
﹤0.01% 474
2024
Q3
$344 Hold
8
﹤0.01% 491
2024
Q2
$362 Hold
8
﹤0.01% 458
2024
Q1
$500 Hold
8
﹤0.01% 443
2023
Q4
$448 Buy
+8
New +$399 ﹤0.01% 452
2017
Q4
Sell
-2,553
Closed -$183K 411
2017
Q3
$183K Buy
+2,553
New +$178K 0.28% 135
2017
Q1
Sell
-22,156
Closed -$1.37M 250
2016
Q4
$1.37M Sell
22,156
-52,157
-70% -$3.08M 0.32% 87
2016
Q3
$4.02M Sell
74,313
-9,124
-11% -$460K 0.96% 40
2016
Q2
$3.8M Buy
+83,437
New +$4.08M 0.94% 48

Other funds holding ENOV

C.M. Bidwell & Associates's ENOV Position: Q2 2025 in Review

C.M. Bidwell & Associates sold out of Enovis (ENOV) in Q2 2025, closing a stake of 8 shares — an estimated $306 sold.

C.M. Bidwell & Associates first reported a position in ENOV in Q2 2016 and held it in 10 quarters. The position peaked at $4.02M in Q3 2016. 285 funds tracked by Wall St. Rank hold ENOV as of Q2 2025.

  • C.M. Bidwell & Associates reported no remaining Enovis position as of Q2 2025 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 8 Enovis shares in Q2 2025, an estimated $306.
  • C.M. Bidwell & Associates first reported a position in Enovis in Q2 2016 and held it in 10 quarters.
  • C.M. Bidwell & Associates's Enovis position peaked at $4.02M in Q3 2016.
  • 285 funds tracked by Wall St. Rank held Enovis as of Q2 2025.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2025, filed 14 Aug 2025.